VKH
SRNE

Virtu KCG Holdings’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Virtu KCG Holdings’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$328K Buy
163,931
+136,506
+498% +$266K 0.01% 1575
2017
Q1 		$108K Buy
+27,425
New +$138K ﹤0.01% 2664
2016
Q4 		– Sell
-21,653
Closed -$168K – 3915
2016
Q3 		$168K Buy
+21,653
New +$146K ﹤0.01% 2456
2015
Q2 		– Sell
-12,995
Closed -$150K – 3888
2015
Q1 		$150K Buy
+12,995
New +$150K ﹤0.01% 2527

Other funds holding SRNE

WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $578M AUM 49.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Virtu KCG Holdings's SRNE Position: Q2 2017 in Review

Virtu KCG Holdings increased its Sorrento Therapeutics, Inc. (SRNE) stake by 498% in Q2 2017, buying an estimated $266K and bringing the position to 163,931 shares worth $328K. The position accounts for 0.01% of the portfolio, ranked #1575.

Virtu KCG Holdings first reported a position in SRNE in Q1 2015 and has held it in 4 quarters since. 46 funds tracked by Wall St. Rank hold SRNE as of Q2 2017.

  • Virtu KCG Holdings held 163,931 shares of Sorrento Therapeutics, Inc. worth $328K as of Q2 2017.
  • Virtu KCG Holdings bought 136,506 Sorrento Therapeutics, Inc. shares in Q2 2017, an estimated $266K.
  • Sorrento Therapeutics, Inc. made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1575 holding.
  • Virtu KCG Holdings first reported a position in Sorrento Therapeutics, Inc. in Q1 2015 and has held it in 4 quarters since.
  • 46 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.